HopeStage
Back to all studies
CompletedNCT00574067

Buprenorphine or counseling for opioid use during prison-to-community transition

About this titleRead the official source — NCT00574067
Medication studyAges 18–60United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
Baltimore and 1 more locationSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2008
Recruitment status
Completed
Enrollment listed in the registry
213
Sponsor
Friends Research Institute, Inc.
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT00574067
Official title
Show the full official title

Buprenorphine for Prisoners

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore · Jessup

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Friends Research Institute, Inc., a research institute.

Did this study involve medication?

Yes. The study involved medication, including Buprenorphine +OTP, Buprenorphine +CHC, Counseling +OTP and Counseling +CHC.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies